RUXX Analysis: New Conflict With Minority Shareholders Can

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
RUXX Analysis: New Conflict With Minority Shareholders Can Affect Russian Miner Mechel's Position

NEW YORK, July 26, 2013 (GLOBE NEWSWIRE) -- Saven Enterprises Ltd, minority shareholder of Tomusinsky Coal Mine , controlled by Mechel OAO, a major Russian mining and metallurgical company, complained to the Russian authorities that Tomusinsky Mine and several production and trading companies affiliated with Mechel OAO transferred profits out of the company by giving out unsecured loans. Saven is seeking to reverse the loans and receive compensation for unpaid dividends. The conflict will likely affect the valuation of Mechel, which is traded on NYSE, according to the research note issued by RUXX, index that tracks Russian equities traded on international exchanges.

Mechel OAO has a history of minority shareholders disputes and transfer pricing accusations. In 2008, Russian then-PM Vladimir Putin complained on national television that Mechel uses unfair pricing schemes that can be considered tax evasion; the infamous press conference caused Mechel stock to drop 40%. In 2008 and 2009, Mechel had another dispute with minority shareholders that spilled over to the media and the courts.

Michael Thompson, RUXX senior analyst, says: "Mechel ADR is one of the few Russian industrial equities traded in New York and we have been following the stock for years. In the last three months, it dropped 38% and is unlikely to go up amid this new conflict. Mechel, despite its industrial nature, is a highly political stock and we believe it's more volatile than the general Russian market, which itself is very volatile."

"According to the arbitrage records, Saven claims that Tomusinsky Mine, controlled by Mechel and its subsidiaries, gave over 3.4bln rubles ($100mln) in loans to companies affiliated with the miner and left the parent company profit-free. This is the typical model for avoiding paying dividends to minority shareholders, and if the court sides with Saven, Mechel will certainly be affected," adds Thompson.

According to Saven's statement, the decisions by Tomusinsky to give unsecured loans were not authorized by the shareholders, which is against standard procedures in Russia. The minority shareholder hopes the court will be able to reverse these decisions.

RUXX analysts believe that Mechel, even though it is fundamentally strong, might be affected by the shareholders disputes and large debt burden (from 2008 to 2012 it went up 60% to $9.6bln).

Russian Industrial Leaders (RUXX) Index tracks Russian stocks traded on international exchanges.

RUXX Index Michael Thompson +1 347 708 0336

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

CES 2025 Audit Shows Record Participation from Tech Leaders

Updated Category News Views 1092

CES 2025 Audit Reveals Attendance Boom CES strengthens as the global convener of the tech ecosystem solving challenges and improving lives The Consumer Technology Association (CTA) has released independently audited data for CES 2025, confirming its place as the most significant tech event worldwide. The audit illustrates a remarkable increase in attendance, attracting...

Continue Reading
Exciting Innovations Unveiled at HR Tech 2025 Next Week

Updated Category News Views 182

Introduction to HR Tech 2025 Next week, the anticipated HR Tech 2025 conference will take place at Mandalay Bay in Las Vegas, showcasing a variety of innovative products poised to revolutionize the human resources space. This esteemed event is known for unveiling cutting-edge technology solutions that address the most pressing challenges faced by HR professionals today....

Continue Reading
Ipsen Expands Oncology Pipeline with ImCheck Acquisition

Updated Category News Views 302

Ipsen Enhances Oncology Focus with Strategic Acquisition Ipsen has taken a significant step in the oncology landscape by announcing its acquisition of ImCheck Therapeutics, a pioneering company in immuno-oncology therapies. This move centers around ImCheck's promising clinical-stage program, ICT01, which targets acute myeloid leukemia (AML), a challenging form of cancer...

Continue Reading
Truxton Wealth Welcomes Tax Expert Matt Winn to Its Team

Updated Category News Views 112

Truxton Wealth Welcomes Matt Winn Truxton Wealth is excited to announce a significant addition to its team with Matt Winn stepping in as Vice President and Wealth & Tax Strategist. This strategic move is poised to enhance the company’s ability to offer tailored tax planning solutions to high-net-worth clients, families, and various business entities. Why Matt Winn is a...

Continue Reading
Sikich Survey Reveals Declining Optimism Among Executives

Updated Category News Views 169

Understanding the Latest Manufacturing Survey Results Recent findings indicate a shift in sentiment among manufacturing executives, revealing cautious optimism in the industry. This shift is highlighted by a survey conducted by Sikich, a leading global technology-enabled professional services firm based in Chicago. The Sikich Industry Pulse survey, gathers valuable...

Continue Reading